RadioGenomics Consortium

The REQUITE project was born out of the international Radiogenomics Consortium (RGC; http://epi.grants.cancer.gov/radiogenomics/). The RGC was established in 2009 by Professor Catharine West (University of Manchester, UK) and Professor Barry Rosenstein (Icahn School of Medicine at Mount Sinai, New York, USA) to facilitate and promote multi-centre collaboration between international researchers working to link genetic variants with response to radiation therapy. Academics interested and/or working in the field of radiogenomics are invited to join the consortium. The Radiogenomics Consortium is a Cancer Epidemiology Consortium supported by the Epidemiology and Genetics Research Program of the National Cancer Institute of the National Institutes of Health.